Literature DB >> 9394074

Carbimazole induced agranulocytosis: rescue with human recombinant granulocyte colony stimulating factor.

J A O'Hare1, T Azher.   

Abstract

We report on a 25 yr old woman with primary autoimmune hyperthyroidism who was treated with carbimazole. Forty-three days later she developed agranulocytosis (64 x 10(6)/l). With 4 days treatment with recombinant human Granulocyte Colony Stimulating factor the granulocyte count rose to normal--4,350 cells x 10(6)/l. This is considerably faster than the rate of spontaneous recovery which usually takes one to 2 weeks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9394074     DOI: 10.1007/bf02944242

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  6 in total

Review 1.  Haemopoietic growth factors 2: clinical applications.

Authors:  D Metcalf
Journal:  Lancet       Date:  1989-04-22       Impact factor: 79.321

2.  Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring.

Authors:  J Tajiri; S Noguchi; T Murakami; N Murakami
Journal:  Arch Intern Med       Date:  1990-03

3.  Methimazole-induced agranulocytosis and granulocyte-colony stimulating factor.

Authors:  B Heinrich; M Gross; F D Goebel
Journal:  Ann Intern Med       Date:  1989-10-01       Impact factor: 25.391

Review 4.  Antithyroid drugs.

Authors:  D S Cooper
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

5.  Drug-induced immunological neutropenia.

Authors:  S A Weitzman; T P Stossel
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

6.  Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF).

Authors:  H Tamai; T Mukuta; S Matsubayashi; S Fukata; G Komaki; K Kuma; L F Kumagai; S Nagataki
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.